Clinical Trials Directory

Trials / Completed

CompletedNCT04242394

If Chronic Gallbladder Diseases Increase the Incidence of PEC

If Chronic Gallbladder Diseases Increase the Occurence of Post Endoscopic Retrograde Choledochopancreatography Choledocholithiasis(a Prospective Multi-center Cohort Study)

Status
Completed
Phase
Study type
Observational
Enrollment
1,019 (actual)
Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-centre trial conducts at 4 ERCP centers in China designed to determine if chronic gallbladder diseases increase the incidence of Post-Endoscopic Retrograde Choledochopancreatography-Choledocholithiasis (PEC)

Detailed description

Endoscopic Retrograde Choledochopancreatography(ERCP) has the advantages of less injury and faster recovery for common bile duct stone patients. However, according to our retrospective study, ERCP will has a mostly 10% possibility to get an acute purulent cholecystitis which often requires emergency intervention, when patients combined with chronic gallbladder diseases, such as chronic cholecystitis, asymptomatic gallstones, and gallbladder wall thickness, the incidence of PEC will increase accordingly. The aim of this study is to observe if chronic gallbladder disease will increase the occurence of PEC and develop a high-risk PEC model.

Conditions

Interventions

TypeNameDescription
PROCEDUREERCPRoutine ERCP procedures with gallbladder in situ patient

Timeline

Start date
2020-02-14
Primary completion
2024-11-16
Completion
2024-11-16
First posted
2020-01-27
Last updated
2025-12-19

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04242394. Inclusion in this directory is not an endorsement.